Research Manitoba is pleased to announce a $250,000 investment to support two COVID-19 Innovation Proof-of-Concept (IPoC) Grants to local companies Adva Diagnostics Inc.(a venture of InnovoXL) and Cubresa Inc. These grants will support innovative research projects from these Manitoba-based companies who have the expertise to help fight the COVID-19 pandemic.
Adva Diagnostic Inc., received $150,000 for their project to develop new on the spot tests for COVID-19 and other infectious diseases, which can help us safely return to work and more normal lives. Adva will provide $33,750 in-kind toward their IPoC Grant with an additional $112,500 from Mitacs.
Cubresa Inc. received $100,000, which builds on their expertise in creating new imaging tools, making them safe to use with highly infectious diseases like SARS COV-2. This is a critical step to understanding and developing new treatments for the disease. Cubresa will provide $36,500 in-kind toward their IPoC Grant.